Demant
Health Care Equipment
Denmark
ESRS disclosure: S4-4_16
Tags Tree
Selected: 0
No matching results found.
- Provide detailed information regarding the intended or achieved positive outcomes of your company's programmes or processes for consumers and end-users. This should include the process for setting targets related to managing material negative impacts, advancing positive impacts, and managing material risks and opportunities. Specify whether and how your company engaged directly with consumers and/or end-users, their legitimate representatives, or credible proxies with insight into their situation. Additionally, outline any initiatives or processes based on the needs of affected consumers and/or end-users, including their level of implementation and the effectiveness of actions taken.
-
Question Id: S4-4_16
In 2024, Demant established new targets for advancing positive impacts on people with hearing loss: improving more than 16 million lives by 2030 and increasing awareness by performing hearing tests on more than 2 million people by 2030. The target-setting process involved internal experts and was approved by Demant’s Executive Leadership Team and endorsed by the Board of Directors. Consumers and end-users were not directly involved in the process. Based on the estimated lifetime of hearing aids, the number of hearing aids sold, and fittings made by the Group in 2024, Demant improved 10.9 million lives in 2024.
Report Date: 4Q2024Relevance: 65%